비교리스트

 카트 문의
시장보고서
상품코드
1552522

피하 약물전달 기기 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품 유형별, 사용성별, 유통 채널별, 지역별 - 시장 예측(2024-2032년)

Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, By Usability, By Distribution Channel, and By Region - Market Forecast, 2024-2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 피하 약물전달 기기 세계 시장 규모는 2032년까지 535억 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

피하 약물전달 기기 시장에는 인슐린 펜, 자동 주사기, 주입 펌프 등 피하로 약물을 투여하도록 설계된 제품이 포함됩니다. 이러한 장치는 만성 질환에 대한 통제된 환자 친화적인 약물전달을 촉진하여 복약 순응도와 치료 결과를 개선합니다.

세계 피하 약물전달 기기 시장은 몇 가지 주요 요인으로 인해 강력한 성장세를 보이고 있습니다. 당뇨병, 류마티스 관절염 등 빈번한 약물 투여가 필요한 만성 질환의 유병률 증가는 피하 약물전달 솔루션에 대한 수요를 크게 증가시키고 있습니다. 또한, 기기 설계의 기술적 진보와 통합 모니터링 시스템을 갖춘 스마트 기기의 개발로 환자들의 순응도와 편의성이 향상되고 있습니다.

또한, 정확하고 조절 가능한 투여 요법을 필요로 하는 개인 맞춤형 의료에 대한 새로운 트렌드도 시장 확대에 기여하고 있습니다. 또한, 재택 의료와 자가 투약에 대한 관심이 높아지면서 피하 약물전달 기기의 채택이 가속화되고 있습니다. 이러한 요인들은 장치 기술의 혁신과 함께 시장의 궤도를 계속 형성할 것으로 예상됩니다.

피하 약물전달 기기 시장 보고서 하이라이트

제품 유형별로는 자동 주사기가 피하 약물전달 기기 시장을 주도하고 있습니다. 이는 사용의 용이성, 편의성, 빈번한 자가 투약이 필요한 만성 질환의 유병률 증가에 기인합니다.

사용성 측면에서 일회용 기기는 편의성, 사용 편의성, 환자 및 의료 서비스 제공자에게 어필할 수 있는 감염 위험 감소로 인해 시장에서 압도적인 우위를 점하고 있습니다.

유통 채널에서 병원 약국은 잘 구축된 인프라와 정기적인 투약이 필요한 만성 질환 환자가 많기 때문에 여전히 압도적인 위치를 차지하고 있습니다.

북미가 시장을 독점하고 있는 반면, 아시아태평양은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 피하 약물전달 기기 시장 인사이트

  • 시장 현황
  • 피하 약물전달 기기 시장 역학
    • 성장 촉진요인과 기회
      • 통합 모니터링 기능을 갖춘 스마트 기기의 대두가 시장 성장을 견인
      • 재택 헬스케어 솔루션 수요 증가로 시장 규모가 확대되고 있다
    • 성장 억제요인과 과제
      • 첨단 기기의 고비용
  • PESTEL 분석
  • 피하 약물전달 기기 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 피하 약물전달 기기 시장 : 제품 유형별

  • 주요 조사 결과
  • 소개
  • 오토인젝터
  • 프리필드 시린지
  • 펜형 주사기
  • 웨어러블 인젝터
  • 무바늘 주사기

제6장 세계의 피하 약물전달 기기 시장 : 사용성별

  • 주요 조사 결과
  • 소개
  • 일회용 기기
  • 재사용 가능한 기기

제7장 세계의 피하 약물전달 기기 시장 : 유통 채널별

  • 주요 조사 결과
  • 소개
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 피하 약물전달 기기 시장 : 지역별

  • 주요 조사 결과
  • 소개
  • 북미
    • 북미 : 제품 유형별, 2019-2032년
    • 북미 : 사용성별, 2019-2032년
    • 북미 : 유통 채널별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품 유형별, 2019-2032년
    • 유럽 : 사용성별, 2019-2032년
    • 유럽 : 유통 채널별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 제품 유형별, 2019-2032년
    • 아시아태평양 : 사용성별, 2019-2032년
    • 아시아태평양 : 유통 채널별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 제품 유형별, 2019-2032년
    • 중동 및 아프리카 : 사용성별, 2019-2032년
    • 중동 및 아프리카 : 유통 채널별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품 유형별, 2019-2032년
    • 라틴아메리카 : 사용성별, 2019-2032년
    • 라틴아메리카 : 유통 채널별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 상황

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • AbbVie
  • Medtronic
  • Novo Nordisk
  • Eli Lilly
  • Becton, Dickinson and Company(BD)
  • Johnson & Johnson
  • Insulet Corporation
  • Ypsomed
  • Sanofi
  • Roche
  • Bayer
  • Terumo Corporation
  • Pfizer
  • 3M
  • Dexcom
ksm 24.10.10

The global subcutaneous drug delivery devices market size is expected to reach USD 53.50 billion by 2032, according to a new study by Polaris Market Research. The report "Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type (Auto-Injectors, Pre-filled Syringes, Pen Injectors, Wearable Injectors, and Needle Free Injectors), By Usability, By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The subcutaneous drug delivery devices market encompasses products designed for the administration of medication under the skin, such as insulin pens, auto-injectors, and infusion pumps. These devices facilitate controlled, patient-friendly drug delivery for chronic conditions, improving adherence and therapeutic outcomes.

The global subcutaneous drug delivery devices market is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases such as diabetes and rheumatoid arthritis, which require frequent medication administration, is significantly boosting demand for subcutaneous delivery solutions. Additionally, technological advancements in device design and the development of smart devices with integrated monitoring systems are enhancing patient compliance and convenience.

The emerging trend toward personalized medicine, which necessitates precise and adjustable dosing regimens, is also contributing to the market expansion. Moreover, the growing emphasis on home healthcare and self-administration of medications is further fueling the adoption of subcutaneous drug delivery devices. These factors, coupled with innovations in device technology, are expected to continue shaping the market's trajectory.

Subcutaneous Drug Delivery Devices Market Report Highlights

Based on product type, the auto-injectors segment dominates the subcutaneous drug delivery devices market, driven by their ease of use, convenience, and the growing prevalence of chronic diseases that require frequent self-administration.

By usability, the disposable devices segment holds the dominant position in the market due to their convenience, ease of use, and reduced risk of infection, which appeals to patients and healthcare providers.

In terms of distribution channel, the hospital pharmacies segment remains the dominating segment due to their established infrastructure and the high volume of chronic disease patients requiring regular medication.

North America dominates the market, whereas Asia Pacific is expected to witness the highest growth rate during the forecast period.

Key players in the subcutaneous drug delivery devices market include AbbVie, Medtronic, Novo Nordisk, Eli Lilly, Becton, Dickinson and Company (BD), Johnson & Johnson, Insulet Corporation, Ypsomed, Sanofi, Roche, Bayer, Terumo Corporation, Pfizer, 3M, and Dexcom.

Polaris Market Research has segmented the subcutaneous drug delivery devices market report on the basis of product type, usability, distribution channel, and region.

Subcutaneous Drug Delivery Devices - Product Type Outlook (Revenue - USD Billion, 2019-2032)

  • Auto-Injectors
  • Pre-filled Syringes
  • Pen Injectors
  • Wearable Injectors
  • Needle Free Injectors

Subcutaneous Drug Delivery Devices - Usability Outlook (Revenue - USD Billion, 2019-2032)

  • Disposable Devices
  • Reusable Devices

Subcutaneous Drug Delivery Devices - Distribution Channel Outlook (Revenue - USD Billion, 2019-2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Subcutaneous Drug Delivery Devices - Regional Outlook (Revenue - USD Billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Subcutaneous Drug Delivery Devices Market Insights

  • 4.1. Subcutaneous Drug Delivery Devices Market - Market Snapshot
  • 4.2. Subcutaneous Drug Delivery Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise of Smart Devices with Integrated Monitoring Are Driving Market Growth
      • 4.2.1.2. Growing Demand for Home Healthcare Solutions is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Advanced Devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Subcutaneous Drug Delivery Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Subcutaneous Drug Delivery Devices Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • 5.3. Auto-Injectors
    • 5.3.1. Global Subcutaneous Drug Delivery Devices Market, by Auto-Injectors, by Region, 2019-2032 (USD billion)
  • 5.4. Pre-filled Syringes
    • 5.4.1. Global Subcutaneous Drug Delivery Devices Market, by Pre-filled Syringes, by Region, 2019-2032 (USD billion)
  • 5.5. Pen Injectors
    • 5.5.1. Global Subcutaneous Drug Delivery Devices Market, by Pen Injectors, by Region, 2019-2032 (USD billion)
  • 5.6. Wearable Injectors
    • 5.6.1. Global Subcutaneous Drug Delivery Devices Market, by Wearable Injectors, by Region, 2019-2032 (USD billion)
  • 5.7. Needle Free Injectors
    • 5.7.1. Global Subcutaneous Drug Delivery Devices Market, by Needle Free Injectors, by Region, 2019-2032 (USD billion)

6. Global Subcutaneous Drug Delivery Devices Market, by Usability

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • 6.3. Disposable Devices
    • 6.3.1. Global Subcutaneous Drug Delivery Devices Market, by Disposable Devices, by Region, 2019-2032 (USD billion)
  • 6.4. Reusable Devices
    • 6.4.1. Global Subcutaneous Drug Delivery Devices Market, by Reusable Devices, by Region, 2019-2032 (USD billion)

7. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Subcutaneous Drug Delivery Devices Market, by Hospital Pharmacies, by Region, 2019-2032 (USD billion)
      • 7.3.1.1.
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Subcutaneous Drug Delivery Devices Market, by Retail Pharmacies, by Region, 2019-2032 (USD billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Subcutaneous Drug Delivery Devices Market, by Online Pharmacies, by Region, 2019-2032 (USD billion)

8. Global Subcutaneous Drug Delivery Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Subcutaneous Drug Delivery Devices Market Assessment, By Geography, 2019-2032 (USD billion)
  • 8.3. Subcutaneous Drug Delivery Devices Market - North America
    • 8.3.1. North America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.3.2. North America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.3.3. North America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.3.4. Subcutaneous Drug Delivery Devices Market - U.S.
      • 8.3.4.1. U.S.: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.3.4.2. U.S.: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.3.4.3. U.S.: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.3.5. Subcutaneous Drug Delivery Devices Market - Canada
      • 8.3.5.1. Canada: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.3.5.2. Canada: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.3.5.3. Canada: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.4. Subcutaneous Drug Delivery Devices Market - Europe
    • 8.4.1. Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.4.2. Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.4.3. Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.4. Subcutaneous Drug Delivery Devices Market - UK
      • 8.4.4.1. UK: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.4.2. UK: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.4.3. UK: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.5. Subcutaneous Drug Delivery Devices Market - France
      • 8.4.5.1. France: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.5.2. France: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.5.3. France: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.6. Subcutaneous Drug Delivery Devices Market - Germany
      • 8.4.6.1. Germany: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.6.2. Germany: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.6.3. Germany: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.7. Subcutaneous Drug Delivery Devices Market - Italy
      • 8.4.7.1. Italy: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.7.2. Italy: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.7.3. Italy: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.8. Subcutaneous Drug Delivery Devices Market - Spain
      • 8.4.8.1. Spain: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.8.2. Spain: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.8.3. Spain: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.9. Subcutaneous Drug Delivery Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.9.2. Netherlands: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.9.3. Netherlands: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.10. Subcutaneous Drug Delivery Devices Market - Russia
      • 8.4.10.1. Russia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.10.2. Russia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.10.3. Russia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.11. Subcutaneous Drug Delivery Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.11.2. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.11.3. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.5. Subcutaneous Drug Delivery Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.5.2. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.5.3. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.4. Subcutaneous Drug Delivery Devices Market - China
      • 8.5.4.1. China: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.4.2. China: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.4.3. China: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.5. Subcutaneous Drug Delivery Devices Market - India
      • 8.5.5.1. India: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.5.2. India: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.5.3. India: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.6. Subcutaneous Drug Delivery Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.6.2. Malaysia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.6.3. Malaysia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.7. Subcutaneous Drug Delivery Devices Market - Japan
      • 8.5.7.1. Japan: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.7.2. Japan: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.7.3. Japan: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.8. Subcutaneous Drug Delivery Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.8.2. Indonesia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.8.3. Indonesia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.9. Subcutaneous Drug Delivery Devices Market - South Korea
      • 8.5.9.1. South Korea: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.9.2. South Korea: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.9.3. South Korea: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.10. Subcutaneous Drug Delivery Devices Market - Australia
      • 8.5.10.1. Australia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.10.2. Australia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.10.3. Australia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.11. Subcutaneous Drug Delivery Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.6. Subcutaneous Drug Delivery Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.6.2. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.6.3. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.4. Subcutaneous Drug Delivery Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.4.2. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.4.3. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.5. Subcutaneous Drug Delivery Devices Market - UAE
      • 8.6.5.1. UAE: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.5.2. UAE: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.5.3. UAE: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.6. Subcutaneous Drug Delivery Devices Market - Israel
      • 8.6.6.1. Israel: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.6.2. Israel: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.6.3. Israel: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.7. Subcutaneous Drug Delivery Devices Market - South Africa
      • 8.6.7.1. South Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.7.2. South Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.7.3. South Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.8. Subcutaneous Drug Delivery Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.7. Subcutaneous Drug Delivery Devices Market - Latin America
    • 8.7.1. Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.7.2. Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.7.3. Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.4. Subcutaneous Drug Delivery Devices Market - Mexico
      • 8.7.4.1. Mexico: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.4.2. Mexico: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.4.3. Mexico: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.5. Subcutaneous Drug Delivery Devices Market - Brazil
      • 8.7.5.1. Brazil: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.5.2. Brazil: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.5.3. Brazil: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.6. Subcutaneous Drug Delivery Devices Market - Argentina
      • 8.7.6.1. Argentina: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.6.2. Argentina: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.6.3. Argentina: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.7. Subcutaneous Drug Delivery Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.7.2. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.7.3. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Medtronic
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Novo Nordisk
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton, Dickinson and Company (BD)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Insulet Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Ypsomed
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Roche
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Bayer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Terumo Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pfizer
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. 3M
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Dexcom
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제